PCSK9 Inhibitors ’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study

ConclusionsDuring the first year of availability, the rate of prescription of PCSK9 inhibitors appears below expectations. Patients were mainly in secondary prevention and had been slightly persistent to previous LLTs. During follow-up, the PCSK9 inhibitor monotherapy showed high levels of adherence and persistence. This real-world study sets the stage for future longer-term investigations useful to improve our knowledge on the appropriateness, drug access and public healthcare sustainability of PCSK9 inhibitors.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research